4
Total investments
2
Early stage
0
Mid stage
0
Late stage
3y
Years active
Portfolio
4 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Advisor
Feb 2026
Pre-seed/ Seed. Backing health & deeptech founders advancing healing at scale.
Investor
Jan 2026
Almost every product used in daily life contains molecules derived from nature. From food, to medicines, to materials, 4 billion years of evolution has gifted humanity a wealth of compounds that are integral to the $5T chemical industry. Current approaches to making powerful chemicals from nature are expensive, difficult to scale, and dependent on fragile supply chains. Anzen Industries is building technology to break this constraint. We design and immobilise enzymes in small modular reactors to scale reactions that are otherwise bottlenecked to achieve molecular resilience.
Investor
Sep 2025
The power of data scaling, the success of big models, and the maturity of robotic hardware enable robotic deployments to move beyond those operating in fully structured to operating in semi-structured and unstructured environments.
SceniX has built a hybrid simulation system that provides the full set of capabilities needed for developing and deploying robotics applications. This includes data creation, policy creation, training, evaluation, and on-going predictive monitoring & edge-case discovery. By using our hybrid simulation system, we fundamentally expedite the speed of development and the reliability of deployment.
Experience Β· 5 entries
All (5)
Investments (4)
2026
Investor & Advisor
Feb 2026
Pre-seed/ Seed. Backing health & deeptech founders advancing healing at scale.
Investor
Jan 2026
Almost every product used in daily life contains molecules derived from nature. From food, to medicines, to materials, 4 billion years of evolution has gifted humanity a wealth of compounds that are integral to the $5T chemical industry. Current approaches to making powerful chemicals from nature are expensive, difficult to scale, and dependent on fragile supply chains. Anzen Industries is building technology to break this constraint. We design and immobilise enzymes in small modular reactors to scale reactions that are otherwise bottlenecked to achieve molecular resilience.
2025
Investor
Sep 2025
The power of data scaling, the success of big models, and the maturity of robotic hardware enable robotic deployments to move beyond those operating in fully structured to operating in semi-structured and unstructured environments.
SceniX has built a hybrid simulation system that provides the full set of capabilities needed for developing and deploying robotics applications. This includes data creation, policy creation, training, evaluation, and on-going predictive monitoring & edge-case discovery. By using our hybrid simulation system, we fundamentally expedite the speed of development and the reliability of deployment.
2023
Subject Matter Expert - Network Portfolio Expert Group
Oct 2023
Established in 1964, the Association of the European Self-Care Industry (AESGP) represents the manufacturers of non-prescription medicines, food supplements and self-care medical devices (an area also referred to as consumer healthcare products).
Our mission is to advance responsible self-care, enabling citizens to take better care of their health needs, and to contribute to the sustainability of European healthcare systems.
Investment activity
2023β2026 Β· 4 investments
Recent (last 2 years)Earlier
